Herr Platner Is Taking Democrat Credibility Down With Him
Joe Biden Hijacks Wife's Book Tour With This Announcement
Oh, Here We Go Again: Those Damn Mail-in Ballots Have Severely Cut Into...
Rahm Emanuel Nailed What's Wrong With the Dems in One Sentence
Speaker Mike Johnson Knows What's Ailing Missing GOP Rep, but There's a Catch
Jill Biden Lashed Out at a Former Aide Over Her Book, and It's...
The US Has to Act Now to Ensure We Dominate the Future of...
Nicole Parker’s 'The Two FBIs' and the Battle for the Bureau’s Soul
Our Enemies Lie
TDS Watch: The 'Convicted Felon' Argument
Will Single-Payer Healthcare Champions Ever Offer Something Credible?
Beaufort, the Tehran Grand Bazaar, and Boots on the Ground in Lebanon
Putting Real Pride Into Pride Month
The Looming Fight Over Intellectual Diversity – Restoring the Academy’s Reason for Being
Michigan Rapper Sentenced to 10 Years for $63M Mail Theft Scheme
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order
AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement